Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Investors Business Daily
Investors Business Daily
Technology
PATRICK SEITZ

Synopsys Stock Tumbles As Chip Design Software Firm Misses Estimates

Electronic design automation firm Synopsys late Tuesday badly missed Wall Street's targets for its fiscal third quarter and offered mixed guidance. Synopsys stock dropped in extended trading.

The Sunnyvale, Calif.-based company earned an adjusted $3.39 a share on sales of $1.74 billion in the quarter ended July 31. Analysts polled by FactSet had expected earnings of $3.80 a share on sales of $1.77 billion. In the year earlier period, Synopsys earned an adjusted $3.43 a share on sales of $1.53 billion.

For the current quarter ending Oct. 31, Synopsys forecast adjusted earnings of $2.78 a share on sales of $2.25 billion. That's based on the midpoint of its fiscal Q4 guidance. Wall Street had been modeling earnings of $4.50 a share on sales of $2.01 billion. In the same quarter last year, Synopsys earned an adjusted $3.40 a share on sales of $1.64 billion.

The fiscal Q3 report was the company's first since it completed its $35 billion acquisition of Ansys on July 17. Synopsys is the leader in EDA software for chip design, while Ansys is tops in simulation and analysis software.

"Q3 was a transformational quarter," Chief Executive Sassine Ghazi said in a news release. "Against a challenging geopolitical backdrop, we closed the Ansys acquisition — expanding our portfolio, customer base and opportunity. Now more than ever, Synopsys is the mission-critical partner technology R&D needs to design and deliver AI-powered products."

The company's intellectual property business underperformed during the quarter, Ghazi said.

Synopsys Stock Retreats Late

Chief Financial Officer Shelagh Glaser said Synopsys is "taking a more conservative view of Q4, while guiding another consecutive year of profitable growth."

In after-hours trading on the stock market today, Synopsys stock fell 18% to 495. During the regular session Tuesday, Synopsys stock dipped 0.8% to close at 604.37.

Synopsys stock is in a flat base with a buy point of 651.73, according to IBD MarketSurge charts. Further, Synopsys is on the IBD Tech Leaders list.

Follow Patrick Seitz on X at @IBD_PSeitz for more stories on consumer technology, software and semiconductor stocks.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.